世界の細胞分裂周期7相同体タンパク質キナーゼ市場2021:メーカー別・地域別・種類別・用途別市場予測(~2026)

GlobalInfoResearchが発行した調査報告書(GIR21JY00001)
◆英語タイトル:Global Cell Division Cycle 7 Related Protein Kinase Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
◆商品コード:GIR21JY00001
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2021年7月(※2024年版があります。お問い合わせください。)
◆ページ数:90
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2~3日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

GlobalInfoResearch社の本調査レポートでは、細胞分裂周期7相同体タンパク質キナーゼの世界市場を広く調査・分析し、今後の市場展望をまとめております。細胞分裂周期7相同体タンパク質キナーゼの種類別市場規模(LBS-007、MSK-777、LY-3143921、TAK-931、その他)、用途別市場規模(転移性乳がん、卵巣がん、急性骨髄性白血病、結腸直腸がん、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(企業概要、製品概要、販売量、価格、売上):Eli Lilly and Company、Millennium Pharmaceuticals Inc、Nerviano Medical Sciences Srl、Sierra Oncology Inc、Takeda Pharmaceutical Company Ltd
・メーカー別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:LBS-007、MSK-777、LY-3143921、TAK-931、その他
・用途別分析2016年-2026年:転移性乳がん、卵巣がん、急性骨髄性白血病、結腸直腸がん、その他
・細胞分裂周期7相同体タンパク質キナーゼの北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・細胞分裂周期7相同体タンパク質キナーゼのヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・細胞分裂周期7相同体タンパク質キナーゼのアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・細胞分裂周期7相同体タンパク質キナーゼの南米市場規模2016年-2026年:ブラジル、アルゼンチン
・細胞分裂周期7相同体タンパク質キナーゼの中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
【レポートの概要】

The Cell Division Cycle 7 Related Protein Kinase market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Cell Division Cycle 7 Related Protein Kinase size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Cell Division Cycle 7 Related Protein Kinase market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Cell Division Cycle 7 Related Protein Kinase market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
LBS-007
MSK-777
LY-3143921
TAK-931
Others

Market segment by Application can be divided into
Metastatic Breast Cancer
Ovarian Cancer
Acute Myelocytic Leukemia
Colorectal Cancer
Others

The key market players for global Cell Division Cycle 7 Related Protein Kinase market are listed below:
Eli Lilly and Company
Millennium Pharmaceuticals Inc
Nerviano Medical Sciences Srl
Sierra Oncology Inc
Takeda Pharmaceutical Company Ltd

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Cell Division Cycle 7 Related Protein Kinase product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Cell Division Cycle 7 Related Protein Kinase, with price, sales, revenue and global market share of Cell Division Cycle 7 Related Protein Kinase from 2019 to 2021.
Chapter 3, the Cell Division Cycle 7 Related Protein Kinase competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cell Division Cycle 7 Related Protein Kinase breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Cell Division Cycle 7 Related Protein Kinase market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Cell Division Cycle 7 Related Protein Kinase sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

1 Market Overview
1.1 Cell Division Cycle 7 Related Protein Kinase Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Cell Division Cycle 7 Related Protein Kinase Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 LBS-007
1.2.3 MSK-777
1.2.4 LY-3143921
1.2.5 TAK-931
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Cell Division Cycle 7 Related Protein Kinase Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Metastatic Breast Cancer
1.3.3 Ovarian Cancer
1.3.4 Acute Myelocytic Leukemia
1.3.5 Colorectal Cancer
1.3.6 Others
1.4 Global Cell Division Cycle 7 Related Protein Kinase Market Size & Forecast
1.4.1 Global Cell Division Cycle 7 Related Protein Kinase Sales in Value (2016-2026))
1.4.2 Global Cell Division Cycle 7 Related Protein Kinase Sales in Volume (2016-2026)
1.4.3 Global Cell Division Cycle 7 Related Protein Kinase Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Cell Division Cycle 7 Related Protein Kinase Production Capacity Analysis
1.5.1 Global Cell Division Cycle 7 Related Protein Kinase Total Production Capacity (2016-2026)
1.5.2 Global Cell Division Cycle 7 Related Protein Kinase Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Cell Division Cycle 7 Related Protein Kinase Market Drivers
1.6.2 Cell Division Cycle 7 Related Protein Kinase Market Restraints
1.6.3 Cell Division Cycle 7 Related Protein Kinase Trends Analysis
2 Manufacturers Profiles
2.1 Eli Lilly and Company
2.1.1 Eli Lilly and Company Details
2.1.2 Eli Lilly and Company Major Business
2.1.3 Eli Lilly and Company Cell Division Cycle 7 Related Protein Kinase Product and Services
2.1.4 Eli Lilly and Company Cell Division Cycle 7 Related Protein Kinase Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Millennium Pharmaceuticals Inc
2.2.1 Millennium Pharmaceuticals Inc Details
2.2.2 Millennium Pharmaceuticals Inc Major Business
2.2.3 Millennium Pharmaceuticals Inc Cell Division Cycle 7 Related Protein Kinase Product and Services
2.2.4 Millennium Pharmaceuticals Inc Cell Division Cycle 7 Related Protein Kinase Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Nerviano Medical Sciences Srl
2.3.1 Nerviano Medical Sciences Srl Details
2.3.2 Nerviano Medical Sciences Srl Major Business
2.3.3 Nerviano Medical Sciences Srl Cell Division Cycle 7 Related Protein Kinase Product and Services
2.3.4 Nerviano Medical Sciences Srl Cell Division Cycle 7 Related Protein Kinase Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Sierra Oncology Inc
2.4.1 Sierra Oncology Inc Details
2.4.2 Sierra Oncology Inc Major Business
2.4.3 Sierra Oncology Inc Cell Division Cycle 7 Related Protein Kinase Product and Services
2.4.4 Sierra Oncology Inc Cell Division Cycle 7 Related Protein Kinase Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Takeda Pharmaceutical Company Ltd
2.5.1 Takeda Pharmaceutical Company Ltd Details
2.5.2 Takeda Pharmaceutical Company Ltd Major Business
2.5.3 Takeda Pharmaceutical Company Ltd Cell Division Cycle 7 Related Protein Kinase Product and Services
2.5.4 Takeda Pharmaceutical Company Ltd Cell Division Cycle 7 Related Protein Kinase Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Cell Division Cycle 7 Related Protein Kinase Sales by Manufacturer
3.1 Global Cell Division Cycle 7 Related Protein Kinase Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Cell Division Cycle 7 Related Protein Kinase Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Cell Division Cycle 7 Related Protein Kinase
3.4 Market Concentration Rate
3.4.1 Top 3 Cell Division Cycle 7 Related Protein Kinase Manufacturer Market Share
3.4.2 Top 6 Cell Division Cycle 7 Related Protein Kinase Manufacturer Market Share
3.5 Global Cell Division Cycle 7 Related Protein Kinase Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Cell Division Cycle 7 Related Protein Kinase Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Cell Division Cycle 7 Related Protein Kinase Market Size by Region
4.1.1 Global Cell Division Cycle 7 Related Protein Kinase Sales in Volume by Region (2016-2026)
4.1.2 Global Cell Division Cycle 7 Related Protein Kinase Revenue by Region (2016-2026)
4.2 North America Cell Division Cycle 7 Related Protein Kinase Revenue (2016-2026)
4.3 Europe Cell Division Cycle 7 Related Protein Kinase Revenue (2016-2026)
4.4 Asia-Pacific Cell Division Cycle 7 Related Protein Kinase Revenue (2016-2026)
4.5 South America Cell Division Cycle 7 Related Protein Kinase Revenue (2016-2026)
4.6 Middle East and Africa Cell Division Cycle 7 Related Protein Kinase Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Cell Division Cycle 7 Related Protein Kinase Sales in Volume by Type (2016-2026)
5.2 Global Cell Division Cycle 7 Related Protein Kinase Revenue by Type (2016-2026)
5.3 Global Cell Division Cycle 7 Related Protein Kinase Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Cell Division Cycle 7 Related Protein Kinase Sales in Volume by Application (2016-2026)
6.2 Global Cell Division Cycle 7 Related Protein Kinase Revenue by Application (2016-2026)
6.3 Global Cell Division Cycle 7 Related Protein Kinase Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Cell Division Cycle 7 Related Protein Kinase Sales by Type (2016-2026)
7.2 North America Cell Division Cycle 7 Related Protein Kinase Sales by Application (2016-2026)
7.3 North America Cell Division Cycle 7 Related Protein Kinase Market Size by Country
7.3.1 North America Cell Division Cycle 7 Related Protein Kinase Sales in Volume by Country (2016-2026)
7.3.2 North America Cell Division Cycle 7 Related Protein Kinase Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Cell Division Cycle 7 Related Protein Kinase Sales by Type (2016-2026)
8.2 Europe Cell Division Cycle 7 Related Protein Kinase Sales by Application (2016-2026)
8.3 Europe Cell Division Cycle 7 Related Protein Kinase Market Size by Country
8.3.1 Europe Cell Division Cycle 7 Related Protein Kinase Sales in Volume by Country (2016-2026)
8.3.2 Europe Cell Division Cycle 7 Related Protein Kinase Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Cell Division Cycle 7 Related Protein Kinase Sales by Type (2016-2026)
9.2 Asia-Pacific Cell Division Cycle 7 Related Protein Kinase Sales by Application (2016-2026)
9.3 Asia-Pacific Cell Division Cycle 7 Related Protein Kinase Market Size by Region
9.3.1 Asia-Pacific Cell Division Cycle 7 Related Protein Kinase Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Cell Division Cycle 7 Related Protein Kinase Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Cell Division Cycle 7 Related Protein Kinase Sales by Type (2016-2026)
10.2 South America Cell Division Cycle 7 Related Protein Kinase Sales by Application (2016-2026)
10.3 South America Cell Division Cycle 7 Related Protein Kinase Market Size by Country
10.3.1 South America Cell Division Cycle 7 Related Protein Kinase Sales in Volume by Country (2016-2026)
10.3.2 South America Cell Division Cycle 7 Related Protein Kinase Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Cell Division Cycle 7 Related Protein Kinase Sales by Type (2016-2026)
11.2 Middle East & Africa Cell Division Cycle 7 Related Protein Kinase Sales by Application (2016-2026)
11.3 Middle East & Africa Cell Division Cycle 7 Related Protein Kinase Market Size by Country
11.3.1 Middle East & Africa Cell Division Cycle 7 Related Protein Kinase Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Cell Division Cycle 7 Related Protein Kinase Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Cell Division Cycle 7 Related Protein Kinase Typical Distributors
12.3 Cell Division Cycle 7 Related Protein Kinase Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

...

【掲載企業】

Eli Lilly and Company、Millennium Pharmaceuticals Inc、Nerviano Medical Sciences Srl、Sierra Oncology Inc、Takeda Pharmaceutical Company Ltd

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の細胞分裂周期7相同体タンパク質キナーゼ市場2021:メーカー別・地域別・種類別・用途別市場予測(~2026)(Global Cell Division Cycle 7 Related Protein Kinase Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026)]についてメールでお問い合わせはこちらでお願いします。